PACTR202208575341765

Safety and Efficacy of Adding Nalbuphine to Bupivacaine in Transversus Abdominis Plane Block in Laparoscopic Bariatric Surgery: A Randomised Controlled Trial.

Name: Clinical Trial PACTR202208575341765
Creator: Cairo University Hospitals
Keywords: Surgery; Anaesthesia, Phase 3, drug, clinical trial, Egypt

Efficacy of Nalbuphine in TAP Block

Cairo University Hospitals·Phase 3·Pan Africa Clinical Trials Registry·drugNot yet recruiting

Study focus

Disease/Condition: Surgery; Anaesthesia
Intervention type: drug

Sponsor & location

Primary sponsor: Cairo University Hospitals
Funder: ATEF KAMEL
Location: Egypt

Timeline & enrollment

Phase: Phase 3
Start date: Apr 01, 2023
End date: Jan 01, 1900

Summary

Bariatric surgery is increasing, analgesia is an integral part of anesthetic practice, TAP block provides adequate analgesia; however for limited time.we expect that addition of nalbuphine will prolong and improve the analgesic profileTo determine the effects of nalbuphine addition to bupivacaine on the analgesic profile.

ICD-10 classifications

Other complications of anaesthesiaAnaesthetic, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation

Data source

Registry: Pan Africa Clinical Trials Registry
Trial ID: PACTR202208575341765
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for PACTR202208575341765 through Pure Global AI's free database. This Phase 3 trial is sponsored by Cairo University Hospitals and is currently Not yet recruiting. The study focuses on Surgery; Anaesthesia.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.